MAXIMUNE® 8 is an inactivated oil emulsion vaccine containing three
Infectious Bursal Disease viruses (standard, variant A and E strains), and
three reoviruses including strain S1133 (Tenosynovitis pathotype), strain
2408 (Malabsorption pathotype) and strain SS412 (Distinct serotype from the
S1133 type reovirus and a causative agent of proventriculitis and malabsorption
in broilers). MAXIMUNE® 8 also contains Newcastle Disease virus
and Infectious Bronchitis viruses (Mass 41 and Mass Holland strains). All
viruses in MAXIMUNE® 8 are non-cloned isolates produced in SPF chicken
egg substrates or in bursal of SPF chickens.
The vaccine is recommended for the vaccination of healthy chickens at least
18 weeks of age as an aid in the prevention of Newcastle Disease and
Infectious Bronchitis virus (Mass type). Breeder vaccination also provides
maternal antibodies to progeny of breeder hens for the prevention of Bursal
Disease caused by standard and variant strains and Tenosynovitis and
Malabsorption caused by reoviruses of the standard and SS412 types.
Optimum results with MAXIMUNE® 8 require that chickens are properly primed
with live Infectious Bursal Disease vaccine, Tenosynovitis vaccine and
bronchitis vaccine of the Mass type at least four weeks in advance of administration
of the inactivated vaccine.
ADMINISTRATION AND DOSAGE
Vaccinate chickens with 0.5 ml (1/2 cc) per bird. The vaccine should be administered
by the subcutaneous route in the back of the neck. Refer to the product
label for specific use directions and precautions.
- Store vaccine between
+2°C and +8°C or 35°F and 45°F
- Protect from light
- Do not freeze
1,000 doses in each 500 ml bottle
10 X 1,000 dose bottles/box
20 X 1,000 dose bottles/box
This product contains oil based
adjuvant; accidental injection into
a human may cause a serious
localized reaction. Seek expert
medical attention immediately.